Global Business Travel (GBTG) 10-Q 13 Nov 20 2020 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2020	Nov. 12, 2020
Document Type	10-Q
Document Period End Date	Sep. 30, 2020
Entity Registrant Name	Apollo Strategic Growth Capital
Entity Current Reporting Status	No
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Central Index Key	0001820872
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Amendment Flag	false
Units, each consisting of one Class A ordinary share, $0.00005 par value, and one-third of one warrant
Title of 12(b) Security	Units, each consisting of one Class A ordinary share, $0.00005 par value, and one-third of one warrant
Trading Symbol	APSG.U
Security Exchange Name	NYSE
Class A ordinary shares
Title of 12(b) Security	Class A ordinary shares
Trading Symbol	APSG
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		81,681,000
Warrants
Title of 12(b) Security	Warrants
Trading Symbol	APSG WS
Security Exchange Name	NYSE
Class B ordinary shares
Entity Common Stock, Shares Outstanding		21,562,500

CONDENSED BALANCE SHEET

CONDENSED BALANCE SHEET - USD ($)		Sep. 30, 2020	Dec. 31, 2019
Current assets:
Prepaid expenses			$ 1,854
Total current assets			1,854
Deferred offering costs		$ 971,749	0
Total assets		971,749	1,854
Current liabilities:
Accounts payable and accrued expenses		625,839
Advances from related parties		355,910
Total current liabilities		981,749
Total liabilities		981,749
Commitments and contingencies
Shareholder's equity (deficit):
Preferred shares, $0.00005 par value per share; 1,000,000 shares authorized; none issued and outstanding
Additional paid-in capital		30,824	30,824
Accumulated deficit		(41,902)	(30,048)
Total shareholder's equity (deficit)		(10,000)	1,854
Total liabilities and shareholder's equity (deficit)		971,749	1,854
Class A ordinary shares
Shareholder's equity (deficit):
Ordinary shares
Class B ordinary shares
Shareholder's equity (deficit):
Ordinary shares	[1],[2]	$ 1,078	$ 1,078
[1]	Includes up to 2,812,500 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 4 and 6). The underwriters have 45 days from the date of the prospectus dated October 1, 2020 to exercise their over-allotment option. On November 10, 2020, the Company consummated the sale of additional units (the “Over-Allotment Units”) pursuant to the underwriters’ partial exercise of their over-allotment option. See Note 7.
[2]	Share amounts as of September 30, 2020 and December 31, 2019 have been retroactively restated to account for the share split and subsequent share surrender as discussed in Note 4.

CONDENSED BALANCE SHEET (Parent

CONDENSED BALANCE SHEET (Parenthetical) - $ / shares	9 Months Ended
	Sep. 30, 2020	Sep. 16, 2020	Dec. 31, 2019	Sep. 30, 2019
Preferred stock, par value	$ 0.00005		$ 0.00005
Preferred stock, shares authorized	1,000,000		1,000,000
Preferred stock, shares issued	0		0
Preferred stock, shares outstanding	0		0
Underwriting option period, number of days from prospectus date	45 days
Class A ordinary shares
Common stock, par value	$ 0.00005		$ 0.00005
Common stock, shares authorized	300,000,000		300,000,000
Common stock, shares issued	0		0
Common stock, shares outstanding	0		0
Class B ordinary shares
Common stock, par value	$ 0.00005		$ 0.00005
Common stock, shares authorized	60,000,000		60,000,000
Common stock, shares issued	21,562,500		21,562,500
Common stock, shares outstanding	21,562,500		21,562,500
Maximum shares subject to forfeiture	2,812,500	2,812,500	2,812,500	2,812,500

CONDENSED STATEMENTS OF OPERATI

CONDENSED STATEMENTS OF OPERATIONS - USD ($)		3 Months Ended		9 Months Ended
		Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
REVENUE		$ 0	$ 0	$ 0	$ 0
EXPENSES
Formation and operating costs		10,000		11,854	1,853
TOTAL EXPENSES		10,000		11,854	1,853
Net loss		$ (10,000)		$ (11,854)	$ (1,853)
Class B ordinary shares
EXPENSES
Weighted average shares outstanding of Class B common stock, basic and diluted	[1],[2]	18,750,000	18,750,000	18,750,000	18,750,000
[1]	Excludes up to 2,812,500 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 4 and 6). The underwriters have 45 days from the date of the prospectus dated October 1, 2020 to exercise their over-allotment option. On November 10, 2020, the Company consummated the sale of Over-Allotment Units pursuant to the underwriters’ partial exercise of their over-allotment option. See Note 7
[2]	Share amounts for the three and nine months ended September 30, 2020 and 2019 been retroactively restated to account for the share split and subsequent share surrender as discussed in Note 4.

CONDENSED STATEMENTS OF OPERA_2

CONDENSED STATEMENTS OF OPERATIONS (Parenthetical) - shares	9 Months Ended
	Sep. 30, 2020	Sep. 16, 2020	Dec. 31, 2019	Sep. 30, 2019
Underwriting option period, number of days from prospectus date	45 days
Class B ordinary shares
Maximum shares subject to forfeiture	2,812,500	2,812,500	2,812,500	2,812,500

CONDENSED STATEMENTS OF CHANGES

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDER'S EQUITY (DEFICIT) - USD ($)		Ordinary sharesClass B ordinary shares		Additional Paid-in Capital	Accumulated Deficit	Total
Balance at the beginning at Dec. 31, 2018		$ 1,078	[1],[2]	$ 27,117	$ (28,195)
Balance at the beginning (in shares) at Dec. 31, 2018	[1],[2]	21,562,500
Capital contributions				3,707		$ 3,707
Net loss					(1,853)	(1,853)
Balance at the ending at Sep. 30, 2019		$ 1,078	[1],[2]	30,824	(30,048)	1,854
Balance at the ending (in shares) at Sep. 30, 2019	[1],[2]	21,562,500
Balance at the beginning at Jun. 30, 2019		$ 1,078	[1],[2]	28,970	(30,048)
Balance at the beginning (in shares) at Jun. 30, 2019	[2]	21,562,500
Capital contributions				1,854		1,854
Balance at the ending at Sep. 30, 2019		$ 1,078	[1],[2]	30,824	(30,048)	1,854
Balance at the ending (in shares) at Sep. 30, 2019	[1],[2]	21,562,500
Balance at the beginning at Dec. 31, 2019		$ 1,078	[1],[3]	30,824	(30,048)	1,854
Balance at the beginning (in shares) at Dec. 31, 2019	[1],[3]	21,562,500
Net loss					(11,854)	(11,854)
Balance at the ending at Sep. 30, 2020		$ 1,078	[1],[3]	30,824	(41,902)	(10,000)
Balance at the ending (in shares) at Sep. 30, 2020	[1],[3]	21,562,500
Balance at the beginning at Jun. 30, 2020		$ 1,078	[1],[3]	30,824	(31,902)
Balance at the beginning (in shares) at Jun. 30, 2020	[1],[3]	21,562,500
Net loss					(10,000)	(10,000)
Balance at the ending at Sep. 30, 2020		$ 1,078	[1],[3]	$ 30,824	$ (41,902)	$ (10,000)
Balance at the ending (in shares) at Sep. 30, 2020	[1],[3]	21,562,500
[1]	Includes up to 2,812,500 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 4 and 6). The underwriters have 45 days from the date of the prospectus dated October 1, 2020 to exercise their over-allotment option. On November 10, 2020, the Company consummated the sale of Over-Allotment Units pursuant to the underwriters’ partial exercise of their over-allotment option. See Note 7.
[2]	Share amounts for the three and nine months ended September 30, 2019, June 30, 2019 and December 19, 2018 have been retroactively restated to account for the share split and subsequent share surrender as discussed in Note 4.
[3]	Share amounts as of September 30, 2020, June 30, 2020 and December 31, 2019 have been retroactively restated to account for the share split and subsequent share surrender as discussed in Note 4.

CONDENSED STATEMENTS OF CHANG_2

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDER'S EQUITY (DEFICIT) (Parenthetical) - shares	9 Months Ended
	Sep. 30, 2020	Sep. 16, 2020	Dec. 31, 2019	Sep. 30, 2019
Underwriting option period, number of days from prospectus date	45 days
Class B ordinary shares
Maximum shares subject to forfeiture	2,812,500	2,812,500	2,812,500	2,812,500

CONDENSED STATEMENTS OF CASH FL

CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash Flows from Operating Activities:
Net loss	$ (11,854)	$ (1,853)
Adjustments to reconcile net loss to net cash used in operating activities:
Formation and operating costs paid by related parties	10,000	3,707
Changes in operating assets and liabilities:
Prepaid expenses	1,854	(1,854)
Net Cash Used In Operating Activities	0	0
Net change in cash	0	0
Cash at beginning of period	0	0
Cash at end of period	0	0
Supplemental disclosure of non-cash financing activities:
Operating costs paid by related party which were charged to additional paid-in capital		$ 3,707
Deferred offering costs included in accrued offering costs	625,839
Deferred offering costs paid by related party	$ 345,910

Description of Organization and

Description of Organization and Business Operations	9 Months Ended
	Sep. 30, 2020
Description of Organization and Business Operations
Description of Organization and Business Operations	1. Description of Organization and Business Operations Organization and General Apollo Strategic Growth Capital (formerly known as APH III (Sub I), Ltd.) (the “ Company ”, “ we ”, “ us ” or “ our ”) was initially incorporated in the Cayman Islands on October 10, 2008 under the name of APH III (Sub I), Ltd. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “ Initial Business Combination ”). The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “ Securities Act ”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “ JOBS Act ”). On August 6, 2020, the Company formally changed its name to Apollo Strategic Growth Capital. At September 30, 2020, the Company had not commenced any operations. All activity for the period from January 1, 2018 through September 30, 2020 relates to the Company’s formation and the initial public offering (the “ Initial Public Offering ”) described below. On October 6, 2020, the Company closed its Initial Public Offering (See Note 3 and Note 7). The Company will not generate any operating revenues until after completion of its Initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the net proceeds derived from the Initial Public Offering. Sponsor and Financing The Company’s sponsor is APSG Sponsor, L.P., a Cayman Islands limited partnership (the “ Sponsor ”). The Company intends to finance its Initial Business Combination with proceeds from the $750,000,000 Initial Public Offering of Units (as defined in Note 3 below) and the $17,000,000 private placement (Note 4). Upon the closing of the Initial Public Offering and the private placement on October 6, 2020, $750,000,000 was placed in a trust account (the “ Trust Account ”) (discussed below). As of the date of this filing, the underwriters have yet to exercise their over-allotment option. On November 10, 2020, the Company consummated the sale of Over-Allotment Units pursuant to the underwriters’ partial exercise of their over-allotment option. See Note 7. Trust Account The proceeds held in the Trust Account will be invested only in U.S. government securities with a maturity of 180 days or less or in money market funds that meet certain conditions under Rule 2a‑7 under the Investment Company Act of 1940, as amended, and that invest only in direct U.S. government treasury obligations, as determined by the Company. Funds will remain in the Trust Account until the earlier of (i) the consummation of the Initial Business Combination or (ii) the distribution of the Trust Account proceeds as described below. The remaining proceeds outside the Trust Account may be used to pay for business, legal and accounting due diligence on prospective acquisitions and continuing general and administrative expenses. Upon closing of the Initial Public Offering on October 6, 2020, the proceeds of the Initial Public Offering of $750,000,000 were held in cash and subsequently invested in U.S. government securities, as specified above. The Company’s amended and restated memorandum and articles of association provides that, other than the withdrawal of interest to pay its tax obligations (the “ Permitted Withdrawals ”), and up to $100,000 of interest to pay dissolution expenses none of the funds held in the Trust Account will be released until the earliest of: (i) the completion of the Initial Business Combination; (ii) the redemption of any Class A ordinary shares included in the Units (the “ Public Shares ”) sold in the Initial Public Offering that have been properly tendered in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association to affect the substance or timing of its obligation to redeem 100% of such Public Shares if it has not consummated an Initial Business Combination within 24 months from the closing of the Initial Public Offering, or 27 months from the closing of the Initial Public Offering if the Company has executed a letter of intent, agreement in principle or definitive agreement for an Initial Business Combination within 24 months from the closing of the Initial Public Offering but have not completed the Initial Business Combination within such 24‑month period (the “ Completion Window ”); or (iii) the redemption of 100% of the Public Shares if the Company is unable to complete an Initial Business Combination within the Completion Window. The proceeds deposited in the Trust Account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public shareholders. Initial Business Combination The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering, although substantially all of the net proceeds of the Initial Public Offering are intended to be generally applied toward consummating an Initial Business Combination. The Initial Business Combination must occur with one or more target businesses that together have a fair market value of at least 80% of the assets held in the Trust Account (excluding the deferred underwriting discounts and commissions and taxes payable on interest earned on the Trust Account) at the time of the agreement to enter into the Initial Business Combination. Furthermore, there is no assurance that the Company will be able to successfully effect an Initial Business Combination. The Company, after signing a definitive agreement for an Initial Business Combination, will either (i) seek shareholder approval of the Initial Business Combination at a meeting called for such purpose in connection with which shareholders may seek to redeem their Public Shares, regardless of whether they vote for or against the Initial Business Combination, for cash equal to their pro rata share of the aggregate amount on deposit in the Trust Account as of two business days prior to the consummation of the Initial Business Combination, including interest not previously released to the Company to pay its franchise and income taxes, or (ii) provide shareholders with the opportunity to sell their Public Shares to the Company by means of a tender offer (and thereby avoid the need for a shareholder vote) for an amount in cash equal to their pro rata share of the aggregate amount on deposit in the Trust Account as of two business days prior to the consummation of the Initial Business Combination, including interest not previously released to the Company to pay its franchise and income taxes. The decision as to whether the Company will seek shareholder approval of the Initial Business Combination or will allow shareholders to sell their Public Shares in a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require the Company to seek shareholder approval, unless a vote is required by law or under NYSE rules. If the Company seeks shareholder approval, it will complete its Initial Business Combination only if a majority of the outstanding ordinary shares voted are voted in favor of the Initial Business Combination. However, in no event will the Company redeem its Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001. In such case, the Company would not proceed with the redemption of its Public Shares and the related Initial Business Combination, and instead may search for an alternate Initial Business Combination. If the Company holds a shareholder vote or there is a tender offer for shares in connection with an Initial Business Combination, a shareholder will have the right to redeem his, her or its Public Shares for an amount in cash equal to his, her or its pro rata share of the aggregate amount on deposit in the Trust Account as of two business days prior to the consummation of the Initial Business Combination, including interest not previously released to make Permitted Withdrawals. As a result, such Public Shares are recorded at redemption amount and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with the Financial Accounting Standards Board (“ FASB ”) Accounting Standards Codification (“ ASC ”) 480, “ Distinguishing Liabilities from Equity .” Pursuant to the Company’s amended and restated memorandum and articles of association, if the Company is unable to complete the Initial Business Combination within the Completion Window, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter subject to lawfully available funds therefor, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to make Permitted Withdrawals (less up to $100,000 of such net interest to pay dissolution expenses and net of taxes payable), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. The Sponsor and the Company’s officers and directors have entered into a letter agreement with the Company, pursuant to which they have agreed to waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares (as defined below) held by them if the Company fails to complete the Initial Business Combination within the Completion Window. However, if the Sponsor or any of the Company’s directors, officers or affiliates acquires Class A ordinary shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete the Initial Business Combination within the prescribed time period. In the event of a liquidation, dissolution or winding up of the Company after an Initial Business Combination, the Company’s shareholders are entitled to share ratably in all assets remaining available for distribution to them after payment of liabilities and after provision is made for each class of ordinary share, if any, having preference over the ordinary shares. The Company’s shareholders have no preemptive or other subscription rights. There are no sinking fund provisions applicable to the ordinary shares, except that the Company will provide its shareholders with the opportunity to redeem their Public Shares for cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account, upon the completion of the Initial Business Combination, subject to the limitations described herein.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2020
Summary of Significant Accounting Policies
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed interim financial statements of the Company are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“ U.S. GAAP ”) and pursuant to the accounting and disclosure rules and regulations of the SEC, and reflect all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation of the financial position as of September 30, 2020 and the results of operations and cash flows for the periods presented. Certain information and disclosures normally included in financial statements prepared in accordance with GAAP have been omitted pursuant to such rules and regulations. Operating results for the three and nine months ended September 30, 2020, are not necessarily indicative of the results that may be expected for the year ending December 31, 2020. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act, and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Liquidity and Capital Resources As of October 6, 2020, due to the consummation of the Initial Public Offering, the Company had investments held in the Trust Account of $750,000,000 consisting of cash and subsequently invested in U.S. government securities. Interest income on the balance in the Trust Account may be used by the Company to pay taxes, and to pay up to $100,000 of any dissolution expenses. As of September 30, 2020, the Company does not have sufficient liquidity to meet its anticipated obligations over the next year from the date of issuance of these financial statements. In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ ASU ”) 2014‑15, “ Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern ,” management has determined that the Company has access to funds from the Sponsor that are sufficient to fund the working capital needs of the Company until a potential business combination or one year from the date of issuance of these financial statements. On October 20, 2020, the Sponsor executed a second promissory note (the “ October Note ”) with a principal amount of $1,500,000. The October Note bears interest at a rate of 0.14% per annum and is payable on the earlier of an Initial Business Combination or the liquidation of the Company. On October 20, 2020, the Company borrowed $1,500,000 pursuant to the October Note. Upon closing of the Initial Public Offering on October 6, 2020, the Company had investments held in the Trust Account of $750,000,000 consisting of cash and subsequently invested in U.S. government securities. Interest income on the balance in the Trust Account may be used by the Company to pay taxes, and to pay up to $100,000 of any dissolution expenses. The Company intends to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account, excluding the deferred underwriting commissions, to complete its Initial Business Combination. To the extent that capital stock or debt is used, in whole or in part, as consideration to complete the Initial Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue growth strategies. If an Initial Business Combination agreement requires the Company to use a portion of the cash in the Trust Account to pay the purchase price, or requires the Company to have a minimum amount of cash at closing, the Company will need to reserve a portion of the cash in the Trust Account to meet such requirements, or arrange for third-party financing. The Company has until October 6, 2022 to complete an Initial Business Combination. If the Company is unable to complete an Initial Business Combination by October 6, 2022, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, and subject to having lawfully available funds therefor, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the trust account deposits (which interest shall be net of taxes payable and less up to $100,000 to pay dissolution expenses), divided by the number of then-outstanding public shares, which redemption will completely extinguish the public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law; and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Cayman Islands’ law to provide for claims of creditors and the requirements of other applicable law. The underwriters have agreed to waive their rights to their deferred underwriting commissions held in the trust account in the event the Company does not complete an Initial Business Combination by October 6, 2022 and, in such event, such amounts will be included with the funds held in the trust account that will be available to fund the redemption of the public shares. Use of Estimates The preparation of the financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “ Fair Value Measurements and Disclosures ,” approximates the carrying amounts represented in the balance sheets. Cash and cash equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash or cash equivalents as of September 30, 2020 and December 31, 2019. Deferred Offering Costs associated with the Initial Public Offering The Company complies with the requirements of FASB ASC 340‑10‑S99‑1 and SEC Staff Accounting Bulletin (“ SAB ”) Topic 5A — “ Expenses of Offering .” Deferred offering costs consist of costs incurred in connection with preparation for the Initial Public Offering. These costs, together with the underwriting discounts and commissions, were charged to additional paid in capital upon completion of the Initial Public Offering. At September 30, 2020 and December 31, 2019, the Company had deferred offering costs of $971,749 and $0, respectively. Upon completion of the Initial Public Offering on October 6, 2020, offering costs of $2,291,710 together with the underwriter discount of $41,250,000, were charged to additional paid-in capital. Income Taxes FASB ASC 740, “Income Taxes” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. There were no unrecognized tax benefits as of September 30, 2020 and December 31, 2019. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties at September 30, 2020 and December 31, 2019. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. Net Loss Per Ordinary Share Net loss per ordinary share is computed by dividing net loss attributable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period, plus, to the extent dilutive, the incremental number of ordinary shares to settle warrants, as calculated using the treasury stock method. Weighted average shares were reduced for the effect of an aggregate of 2,812,500 ordinary shares that will be surrendered to the Company if the over-allotment option is not exercised by the underwriters. The underwriters have 45 days from the date of the prospectus dated October 1, 2020 to exercise their over-allotment option. On November 10, 2020, the Company consummated the sale of Over-Allotment Units pursuant to the underwriters’ partial exercise of their over-allotment option. See Note 7. At September 30, 2020 and 2019, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company under the treasury stock method. As a result, diluted loss per ordinary share is the same as basic loss per ordinary share for the periods presented. Recent Accounting Pronouncements The Company’s management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

Initial Public Offering

Initial Public Offering	9 Months Ended
	Sep. 30, 2020
Initial Public Offering
Initial Public Offering	3. Initial Public Offering On October 6, 2020, the Company sold 75,000,000 units at a price of $10.00 per unit (the “ Units ”), generating gross proceeds of $750,000,000, and incurring offering costs of $43,541,710, inclusive of $26,250,000 in deferred underwriting commissions. Each Unit consists of one share of the Company’s Class A ordinary shares, $0.00005 par value, and one-third of one warrant (each, a “ Warrant ” and, collectively, the “ Warrants ”). Each whole Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share. No fractional shares will be issued upon separation of the Units and only whole Warrants will trade. The Warrants sold as part of the Units (the “ Public Warrants ”) will become exercisable on the later of (a) 30 days after the completion of an Initial Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their Public Warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of an Initial Business Combination, the Company will use its best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the ordinary shares issuable upon exercise of the Public Warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the Public Warrants in accordance with the provisions of the warrant agreement. Notwithstanding the foregoing, if the Company’s ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under the Securities Act, the Company, at its option, may require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement. The Public Warrants will expire five years after the completion of an Initial Business Combination or earlier upon the Company’s redemption or liquidation. The Company granted the underwriters a 45-day option expiring on November 15, 2020 to purchase up to 11,250,000 additional Units to cover any over-allotments at the Initial Public Offering price less the underwriting discounts and commissions. The Units that will be issued in connection with the exercise of the over-allotment option are identical to the Units issued in the Initial Public Offering. On November 10, 2020, the Company consummated the sale of Over-Allotment Units pursuant to the underwriters’ partial exercise their over-allotment option. See Note 7. The Company paid an underwriting discount of 2.0% of the per Unit offering price, or $15,000,000 in the aggregate, to the underwriters at the closing of the Initial Public Offering, with an additional fee (the “ Deferred Discount ”) of 3.5% of the gross offering proceeds, or $26,250,000, payable upon the Company’s completion of an Initial Business Combination. The Deferred Discount will become payable to the underwriters from the amounts held in the Trust Account solely in the event the Company completes its Initial Business Combination.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2020
Related Party Transactions
Related Party Transactions	4. Related Party Transactions Founder Shares In October 2008, the Company was formed by Apollo Principal Holdings III, L.P. (“ Holdings ”), at which point, one ordinary share was issued in exchange for the payment of operating and formation expenses of the Company. In August 2020, Holdings transferred its ownership in the Company, consisting of one ordinary share, to the Sponsor for no consideration. On August 6, 2020, the Company completed a share split of its ordinary shares and, as a result, 28,750,000 of the Company’s Class B ordinary shares were outstanding (the “ Founder Shares ”). On September 16, 2020, the Sponsor surrendered 7,187,500 ordinary shares, thereby effecting a 1.33333:1 share recapitalization, and, as a result, 21,562,500 of the Company’s Founder Shares were outstanding. The share amounts have been retroactively restated to account for the share split. The initial shareholders have agreed to forfeit up to 2,812,500 Class B ordinary shares to the extent that the over-allotment option is not exercised in full by the underwriters. The forfeiture will be adjusted to the extent that the over-allotment option is not exercised in full by the underwriters so that the Founder Shares will represent 20.0% of the Company’s issued and outstanding shares after the Initial Public Offering. The Founder Shares are identical to the Class A ordinary shares included in the Units sold in the Initial Public Offering except that the Founder Shares are Class B ordinary shares which automatically convert into Class A ordinary shares at the time of the Company’s Initial Business Combination and are subject to certain transfer restrictions, as described in more detail below. The number of Founder Shares issued in the share split was determined based on the expectation that the total size of the Initial Public Offering would be a maximum of 86,250,000 Units if the underwriters’ over-allotment option was exercised in full, and therefore that such Founder Shares would represent 20% of the issued and outstanding ordinary shares after the Initial Public Offering. If the Company increases or decreases the size of the Initial Public Offering, the Company will effect a share dividend or share contribution (or other similar action) back to capital, as applicable, immediately prior to the completion of the Initial Public Offering in such amount as to maintain the Founder Shares at a number equal to 20% of the issued and outstanding ordinary shares after the Initial Public Offering. The holders of the Founder Shares agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A) one year after the completion of the Initial Business Combination or (B) subsequent to the Initial Business Combination, (x) if the last sale price of the Company’s Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30‑trading day period commencing at least 150 days after the Initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Company’s shareholders having the right to exchange their ordinary shares for cash, securities or other property. In September 2020, 25,000 Founder Shares were transferred to each of the Company’s three independent directors at a purchase price of $0.00087 per share. The independent directors paid $65.25 in the aggregate for the 75,000 shares to the Sponsor. Private Placement Concurrently with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 11,333,334 Warrants (the “ Private Placement Warrants ”) at a price of $1.50 per whole warrant ($17,000,000 million in the aggregate) in a private placement. Each whole Private Placement Warrant is exercisable for one whole share of the Company’s Class A ordinary shares at a price of $11.50 per share. A portion of the purchase price of the Private Placement Warrants was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Initial Business Combination is not completed within 24 months from the closing of the Initial Public Offering, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees. The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the Initial Business Combination. Related Party Loans On August 11, 2020, the Sponsor agreed to loan the Company an aggregate of up to $750,000 to cover expenses related to the Initial Public Offering pursuant to an unsecured promissory note (the “ Note ”). This Note bears interest at a rate of 0.17% per annum and is payable on the earlier of March 31, 2021 or the closing date of the Initial Public Offering. As of September 30, 2020 and December 31, 2019, the Company had not borrowed on the Note. Upon the close of the Initial Public Offering on October 6, 2020, the Note expired. On October 20, 2020, the Sponsor executed a second promissory note (the “ October Note ”) to loan the Company an aggregate principal amount of $1,500,000. The October Note bears interest at a rate of 0.14% per annum and is payable on the earlier of an Initial Business Combination or the liquidation of the Company. On October 20, 2020, the Company borrowed $1,500,000 pursuant to the October Note. Advances from Related Parties Affiliates of the Sponsor paid certain formation, operating and offering costs on behalf of the Company. These advances are due on demand and are non-interest bearing. For the period from October 10, 2008 (inception) through September 30, 2020, the related parties paid $355,910 of offering costs and other expenses on behalf of the Company. As of September 30, 2020 and December 31, 2019, there was $355,910 and $0 due to the related parties, respectively. Administrative Support Agreement Commencing on the date the Units were first listed on the NYSE, the Company has agreed to pay the Sponsor a total of $16,667 per month for office space, utilities and secretarial and administrative support for up to 27 months. Upon completion of the Initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2020
Commitments and Contingencies.
Commitments and Contingencies	5. Commitments and Contingencies Registration Rights The holders of the Founder Shares, Private Placement Warrants and Warrants that may be issued upon conversion of working capital loans, if any, (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and Warrants that may be issued upon conversion of working capital loans) will be entitled to registration rights pursuant to a registration rights agreement signed on the effective date of the Initial Public Offering. The holders of these securities are entitled to demand that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of an Initial Business Combination. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45‑day option expiring on November 15, 2020 to purchase up to 11,250,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. On November 10, 2020, the Company consummated the sale of Over-Allotment Units pursuant to the underwriters’ partial exercise their over-allotment option. See Note 7. The underwriters are entitled to a deferred fee of $0.35 per Unit, or $26,250,000 (or $30,187,500 if the over-allotment option is exercised in full) in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes an Initial Business Combination, subject to the terms of the underwriting agreement. Risks and Uncertainties Management continues to evaluate the impact of the COVID‑19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Shareholders' Equity

Shareholders' Equity	9 Months Ended
	Sep. 30, 2020
Shareholders' Equity
Shareholders' Equity	6. Shareholder’s Equity Preferred Shares The Company is authorized to issue 1,000,000 preferred shares with a par value of $0.00005 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At September 30, 2020 and December 31, 2019 there were no preferred shares issued or outstanding. Ordinary Shares The authorized ordinary shares of the Company include up to 300,000,000 Class A ordinary shares and 60,000,000 Class B ordinary shares. If the Company enters into an Initial Business Combination, it may (depending on the terms of such an Initial Business Combination) be required to increase the number of Class A ordinary shares which the Company is authorized to issue at the same time as the Company’s shareholders vote on the Initial Business Combination to the extent the Company seeks shareholder approval in connection with the Initial Business Combination. Holders of the Company’s ordinary shares are entitled to one vote for each ordinary share. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of completion of an Initial Business Combination on a one-for-one basis, subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like and subject to further adjustment as provided herein. In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts sold in the Initial Public Offering and related to the closing of the Initial Business Combination, the ratio at which Class B ordinary shares will convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the outstanding Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all ordinary shares outstanding upon the completion of the Initial Public Offering plus all Class A ordinary shares and equity-linked securities issued or deemed issued in connection with the Initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the Initial Business Combination). As of September 30, 2020 and December 31, 2019, there were 21,562,500 Class B ordinary shares issued and outstanding. Of the 21,562,500 Class B ordinary shares outstanding, up to 2,812,500 Class B ordinary shares are subject to forfeiture to the Company by the initial shareholders for no consideration to the extent that the underwriters’ over-allotment option is not exercised in full or in part, so that the number of Class B ordinary shares will collectively equal 20% of the Company’s issued and outstanding ordinary shares after the Initial Public Offering. Warrants Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of an Initial Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their Public Warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of an Initial Business Combination, the Company will use its best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the ordinary shares issuable upon exercise of the Public Warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the Public Warrants in accordance with the provisions of the warrant agreement. Notwithstanding the foregoing, if the Company’s ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under the Securities Act, the Company, at its option, may require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement. The Public Warrants will expire five years after the completion of an Initial Business Combination or earlier upon the Company’s redemption or liquidation. The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants and the ordinary shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of an Initial Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants are non-redeemable so long as they are held by the initial purchasers or such purchasers’ permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. The Company may redeem the Public Warrants: · in whole and not in part; · at a price of $0.01 per warrant; · upon a minimum of 30 days’ prior written notice of redemption; · if, and only if, the last reported closing price of the Company’s ordinary shares equals or exceeds $18.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30‑trading day period ending on a the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders; and · if, and only if, there is a current registration statement in effect with respect to the ordinary shares underlying such warrants at the time of redemption and a current prospectus relating to those ordinary shares is available throughout the 30‑day trading period referred to above. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of the ordinary shares issuable upon exercise of the Warrants may be adjusted in certain circumstances including in the event of a share dividend, or recapitalization, reorganization, merger or consolidation. However, the Warrants will not be adjusted for issuance of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Warrants. If the Company is unable to complete an Initial Business Combination within the Completion Window and the Company liquidates the funds held in the Trust Account, holders of Warrants will not receive any of such funds with respect to their Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such Warrants. Accordingly, the Warrants may expire worthless.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2020
Subsequent Events
Subsequent Events	7. Subsequent Events On October 6, 2020, the Company consummated the Initial Public Offering of 75,000,000 Units generating gross proceeds of $750,000,000 which is described in Note 3. The Sponsor purchased an aggregate of 11,333,334 Warrants at a purchase price of $1.50 per Warrant, or approximately $17,000,000 in the aggregate, in a private placement simultaneously with the closing of the Initial Public Offering. On October 20, 2020, the Sponsor executed the October Note to loan the Company an aggregate principal amount of $1,500,000. The October Note bears interest at a rate of 0.14% per annum and is payable on the earlier of an Initial Business Combination or the liquidation of the Company. On October 20, 2020, the Company borrowed $1,500,000 pursuant to the October Note. On November 10, 2020, the Company consummated the sale of 6,681,000 Over-Allotment Units pursuant to the underwriters’ partial exercise of their over-allotment option. Such Over-Allotment Units were sold at $10.00 per Unit, generating gross proceeds of $66,810,000. Substantially concurrently with the closing of the sale of 6,681,000 Over-Allotment Units, the Company consummated the private sale of an additional 890,800 Private Placement Warrants at a purchase price of $1.50 per Private Placement Warrant to the Sponsor, generating gross proceeds of $1,336,200. Following the closing of the over-allotment option and sale of additional Private Placement Warrants (together, the “Over-Allotment Closing”), a total of $816,810,000, including approximately $28,588,350 of the underwriters’ deferred discount, was held in the Trust Account. Management has evaluated subsequent events and transactions that occurred through the date the financial statements were available to be issued. Other than as noted above, management did not identify any other subsequent events that would have required adjustment or disclosure in the financial statements.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2020
Summary of Significant Accounting Policies
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed interim financial statements of the Company are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“ U.S. GAAP ”) and pursuant to the accounting and disclosure rules and regulations of the SEC, and reflect all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation of the financial position as of September 30, 2020 and the results of operations and cash flows for the periods presented. Certain information and disclosures normally included in financial statements prepared in accordance with GAAP have been omitted pursuant to such rules and regulations. Operating results for the three and nine months ended September 30, 2020, are not necessarily indicative of the results that may be expected for the year ending December 31, 2020.
Emerging growth company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act, and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”)) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Liquidity and Capital Resources	Liquidity and Capital Resources As of October 6, 2020, due to the consummation of the Initial Public Offering, the Company had investments held in the Trust Account of $750,000,000 consisting of cash and subsequently invested in U.S. government securities. Interest income on the balance in the Trust Account may be used by the Company to pay taxes, and to pay up to $100,000 of any dissolution expenses. As of September 30, 2020, the Company does not have sufficient liquidity to meet its anticipated obligations over the next year from the date of issuance of these financial statements. In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ ASU ”) 2014‑15, “ Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern ,” management has determined that the Company has access to funds from the Sponsor that are sufficient to fund the working capital needs of the Company until a potential business combination or one year from the date of issuance of these financial statements. On October 20, 2020, the Sponsor executed a second promissory note (the “ October Note ”) with a principal amount of $1,500,000. The October Note bears interest at a rate of 0.14% per annum and is payable on the earlier of an Initial Business Combination or the liquidation of the Company. On October 20, 2020, the Company borrowed $1,500,000 pursuant to the October Note. Upon closing of the Initial Public Offering on October 6, 2020, the Company had investments held in the Trust Account of $750,000,000 consisting of cash and subsequently invested in U.S. government securities. Interest income on the balance in the Trust Account may be used by the Company to pay taxes, and to pay up to $100,000 of any dissolution expenses. The Company intends to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account, excluding the deferred underwriting commissions, to complete its Initial Business Combination. To the extent that capital stock or debt is used, in whole or in part, as consideration to complete the Initial Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue growth strategies. If an Initial Business Combination agreement requires the Company to use a portion of the cash in the Trust Account to pay the purchase price, or requires the Company to have a minimum amount of cash at closing, the Company will need to reserve a portion of the cash in the Trust Account to meet such requirements, or arrange for third-party financing. The Company has until October 6, 2022 to complete an Initial Business Combination. If the Company is unable to complete an Initial Business Combination by October 6, 2022, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, and subject to having lawfully available funds therefor, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the trust account deposits (which interest shall be net of taxes payable and less up to $100,000 to pay dissolution expenses), divided by the number of then-outstanding public shares, which redemption will completely extinguish the public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law; and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Cayman Islands’ law to provide for claims of creditors and the requirements of other applicable law. The underwriters have agreed to waive their rights to their deferred underwriting commissions held in the trust account in the event the Company does not complete an Initial Business Combination by October 6, 2022 and, in such event, such amounts will be included with the funds held in the trust account that will be available to fund the redemption of the public shares.
Use of Estimates	Use of Estimates The preparation of the financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Financial Instruments	Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “ Fair Value Measurements and Disclosures ,” approximates the carrying amounts represented in the balance sheets.
Cash and cash equivalents	Cash and cash equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash or cash equivalents as of September 30, 2020 and December 31, 2019.
Deferred Offering Costs associated with the Initial Public Offering	Deferred Offering Costs associated with the Initial Public Offering The Company complies with the requirements of FASB ASC 340‑10‑S99‑1 and SEC Staff Accounting Bulletin (“ SAB ”) Topic 5A — “ Expenses of Offering .” Deferred offering costs consist of costs incurred in connection with preparation for the Initial Public Offering. These costs, together with the underwriting discounts and commissions, were charged to additional paid in capital upon completion of the Initial Public Offering. At September 30, 2020 and December 31, 2019, the Company had deferred offering costs of $971,749 and $0, respectively. Upon completion of the Initial Public Offering on October 6, 2020, offering costs of $2,291,710 together with the underwriter discount of $41,250,000, were charged to additional paid-in capital.
Income Taxes	Income Taxes FASB ASC 740, “Income Taxes” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. There were no unrecognized tax benefits as of September 30, 2020 and December 31, 2019. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties at September 30, 2020 and December 31, 2019. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements.
Net Loss Per Ordinary Share	Net Loss Per Ordinary Share Net loss per ordinary share is computed by dividing net loss attributable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period, plus, to the extent dilutive, the incremental number of ordinary shares to settle warrants, as calculated using the treasury stock method. Weighted average shares were reduced for the effect of an aggregate of 2,812,500 ordinary shares that will be surrendered to the Company if the over-allotment option is not exercised by the underwriters. The underwriters have 45 days from the date of the prospectus dated October 1, 2020 to exercise their over-allotment option. On November 10, 2020, the Company consummated the sale of Over-Allotment Units pursuant to the underwriters’ partial exercise of their over-allotment option. See Note 7. At September 30, 2020 and 2019, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company under the treasury stock method. As a result, diluted loss per ordinary share is the same as basic loss per ordinary share for the periods presented.
Recent Accounting Pronouncements	Recent Accounting Pronouncements The Company’s management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

Description of Organization a_2

Description of Organization and Business Operations (Details) - USD ($)	Nov. 10, 2020	Oct. 06, 2020	Sep. 30, 2020
Description of Organization and Business Operations
Maturity term of U.S. government securities			180 days
Percentage of shares of stock the Company is obligated to redeem without consummating a business combination			100.00%
Percentage of aggregate fair market value of assets			80.00%
Minimum net tangible assets upon consummation of business combination			$ 5,000,001
Threshold trading days to redeem the shares			10 days
Subsequent event
Description of Organization and Business Operations
Investments held in Trust	$ 816,810,000	$ 750,000,000
Maximum interest income on the balance in the Trust Account which may be used to pay dissolution expenses		100,000
Initial Public Offering | Subsequent event
Description of Organization and Business Operations
Proceeds from offering		750,000,000
Offering cost		43,541,710
Deferred underwriting commissions		26,250,000
Over-allotment option | Subsequent event
Description of Organization and Business Operations
Proceeds from offering	66,810,000
Sponsor | Private Placement | Subsequent event
Description of Organization and Business Operations
Proceeds from issuance of warrants	$ 1,336,200	$ 17,000,000

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($)	Oct. 06, 2020	Sep. 30, 2020	Nov. 10, 2020	Oct. 20, 2020	Dec. 31, 2019
Summary of Significant Accounting Policies
Deferred offering costs		$ 971,749			$ 0
Unrecognized tax benefits		0
Amounts accrued for the payment of interest and penalties		$ 0
Weighted average shares reduced to the effect of shares surrendered		2,812,500
Underwriting option period, number of days from prospectus date		45 days
Subsequent event
Summary of Significant Accounting Policies
Investments held in Trust	$ 750,000,000		$ 816,810,000
Maximum interest income on the balance in the Trust Account which may be used to pay dissolution expenses	100,000
October Note | Subsequent event
Summary of Significant Accounting Policies
Offering costs charged to APIC	2,291,710
Underwriter discounts charged to APIC	$ 41,250,000
Sponsor | October Note | Subsequent event
Summary of Significant Accounting Policies
Principal amount of promissory note				$ 1,500,000
Interest rate per annum				0.14%
Amount borrowed				$ 1,500,000

Initial Public Offering (Detail

Initial Public Offering (Details) - USD ($)	Nov. 10, 2020	Oct. 06, 2020	Sep. 30, 2020	Dec. 31, 2019
Public Offering
Underwriting option period, number of days from prospectus date			45 days
Percentage of underwriting discount			2.00%
Cash underwriting discount paid			$ 15,000,000
Percentage of deferred fee			3.50%
Deferred underwriting fee payable			$ 26,250,000
Public Warrants
Public Offering
Warrants exercisable term after the completion of a business combination			30 days
Warrants exercisable term from the closing of the public offering			12 months
Threshold maximum period for filing registration statement after business combination			15 days
Warrant expiry term			5 years
Class A ordinary shares
Public Offering
Common stock, par value			$ 0.00005	$ 0.00005
Initial Public Offering | Subsequent event
Public Offering
Number of units issued		75,000,000
Price per unit		$ 10
Proceeds from offering		$ 750,000,000
Offering cost		43,541,710
Deferred underwriting commissions		$ 26,250,000
Over-allotment option
Public Offering
Exercise price of warrants (in dollars per share)			$ 11.50
Underwriting option period, number of days from prospectus date			45 days
Additional units which may be issued			11,250,000
Deferred underwriting fee payable			$ 26,250,000
Over-allotment option | Subsequent event
Public Offering
Number of units issued	6,681,000
Price per unit	$ 10
Proceeds from offering	$ 66,810,000

Related Party Transactions - Fo

Related Party Transactions - Founder share (Details)	Aug. 06, 2020shares	Sep. 30, 2020$ / sharesshares	Sep. 16, 2020shares	Dec. 31, 2019$ / sharesshares	Sep. 30, 2019shares
Sponsor
Related Party Transactions
Share price | $ / shares		$ 65.25
Number of shares issued		75,000
Common Stock, Shares, Outstanding			7,187,500
Founder
Related Party Transactions
Share price | $ / shares		$ 0.00087
Number of shares issued		25,000
Common Stock, Shares, Outstanding			21,562,500
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders		20.00%
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) | $ / shares		$ 12
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination		20
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences		150 days
Class B ordinary shares
Related Party Transactions
Common Stock, Shares, Outstanding		21,562,500		21,562,500
Ordinary shares, par value | $ / shares		$ 0.00005		$ 0.00005
Maximum shares subject to forfeiture		2,812,500	2,812,500	2,812,500	2,812,500
Common stock, shares subject to forfeiture, as a percent of issued and outstanding shares (as a percent)			20.00%
Class B ordinary shares | Founder
Related Party Transactions
Common Stock, Shares, Outstanding	28,750,000
Recapitalization ratio	1.33333
Over-allotment option | Founder
Related Party Transactions
Number of shares issued		86,250,000

Related Party Transactions - Pr

Related Party Transactions - Private placement warrants (Details) - Private Placement - Sponsor - Subsequent event - USD ($)	Nov. 10, 2020	Oct. 06, 2020
Related Party Transactions
Number of warrants to purchase the shares issued (in shares)	890,800	11,333,334
Price of warrants (in dollars per share)		$ 1.50
Proceeds from Issuance of Warrants	$ 1,336,200	$ 17,000,000
Threshold Period For Not To Transfer, Assign Or Sell Any Shares Or Warrants After Completion Of Initial Business Combination		30 days
Class A ordinary shares
Related Party Transactions
Price of warrants (in dollars per share)		$ 11.50

Related Party Transactions - Re

Related Party Transactions - Related Party Loans (Details) - Sponsor - USD ($)	Oct. 20, 2020	Aug. 11, 2020
Note
Related Party Transactions
Principal amount of promissory note		$ 750,000
Interest rate per annum		0.17%
October Note | Subsequent event
Related Party Transactions
Principal amount of promissory note	$ 1,500,000
Interest rate per annum	0.14%
Amount borrowed	$ 1,500,000

Related Party Transactions - Ad

Related Party Transactions - Advances from Related Parties, Administrative Support Agreement (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Related Party Transactions
Due to the related parties	$ 355,910
Threshold period for which expenses are paid	27 months
Advances from Related Parties
Related Party Transactions
Offering costs and other expenses	$ 355,910	$ 0
Due to the related parties	355,910
Administrative Support Agreement
Related Party Transactions
Expenses per month	$ 16,667

Commitments and Contingencies (

Commitments and Contingencies (Details)	9 Months Ended
	Sep. 30, 2020USD ($)$ / sharesshares
Underwriting Agreement
Underwriting option period, number of days from prospectus date	45 days
Deferred underwriting fee payable	$ 26,250,000
Over-allotment option
Underwriting Agreement
Underwriting option period, number of days from prospectus date	45 days
Additional units which may be issued | shares	11,250,000
Deferred fee per unit | $ / shares	$ 0.35
Deferred underwriting fee payable	$ 26,250,000
Over-allotment option | If underwriters' over-allotment option is exercised in full
Underwriting Agreement
Deferred underwriting fee payable	$ 30,187,500

Shareholders' Equity - Preferre

Shareholders' Equity - Preferred Shares (Details) - $ / shares	Sep. 30, 2020	Dec. 31, 2019
Shareholders' Equity
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, par value	$ 0.00005	$ 0.00005
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0

Shareholders' Equity - Ordinary

Shareholders' Equity - Ordinary Shares (Details)	9 Months Ended
	Sep. 30, 2020Vote / shares$ / sharesshares	Dec. 31, 2019$ / sharesshares
Shareholders' Equity
Number of vote for each ordinary share | Vote / shares	1
Number of Class A common stock issued upon conversion of each share (in shares)	1
Number of common stock issuable pursuant to Initial Business Combination, as a percent of outstanding shares (in shares)	20.00%
Common stock, number of votes per share | Vote / shares	1
Class A ordinary shares
Shareholders' Equity
Common stock, shares authorized	300,000,000	300,000,000
Common stock, par value | $ / shares	$ 0.00005	$ 0.00005
Common stock, shares issued	0	0
Common stock, shares outstanding	0	0
Class B ordinary shares
Shareholders' Equity
Common stock, shares authorized	60,000,000	60,000,000
Common stock, par value | $ / shares	$ 0.00005	$ 0.00005
Common stock, shares issued	21,562,500	21,562,500
Common stock, shares outstanding	21,562,500	21,562,500
Common stock, shares subject to forfeiture (in shares)	2,812,500	2,812,500

Shareholders' Equity - Warrants

Shareholders' Equity - Warrants (Details)	9 Months Ended
	Sep. 30, 2020$ / shares
Public Warrants
Shareholders' Equity
Warrants exercisable term after the completion of a business combination	30 days
Warrants exercisable term from the closing of the public offering	12 months
Threshold maximum period for filing registration statement after business combination	15 days
Warrant expiry term	5 years
Public Warrants | Redemption of Warrants when price per share of Class A common stock equals or exceeds $18.00
Shareholders' Equity
Redemption price per warrant (in dollars per share)	$ 0.01
Minimum threshold written notice period for redemption of public warrants	30 days
Stock price trigger for redemption of warrants (in dollars per share)	$ 18
Threshold trading days for redemption of warrants	20 days
Threshold consecutive trading days for redemption of warrants	30 days
Private Placement Warrants
Shareholders' Equity
Warrants exercisable term after the completion of a business combination	30 days

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent event - USD ($)	Nov. 10, 2020	Oct. 06, 2020	Oct. 20, 2020
Subsequent Events
Total assets held in Trust Account	$ 816,810,000	$ 750,000,000
Portion of assets held in Trust Account attributable to underwriters' deferred discount	$ 28,588,350
Sponsor | October Note
Subsequent Events
Principal amount of promissory note			$ 1,500,000
Interest rate per annum			0.14%
Amount borrowed			$ 1,500,000
Initial Public Offering
Subsequent Events
Number of units issued		75,000,000
Price per unit		$ 10
Gross proceeds from issuance		$ 750,000,000
Private Placement | Sponsor
Subsequent Events
Warrants to purchase shares of common stock	890,800	11,333,334
Purchase price per warrant	$ 1.50	$ 1.50
Proceeds from warrants exercises	$ 1,336,200	$ 17,000,000
Over-allotment option
Subsequent Events
Number of units issued	6,681,000
Price per unit	$ 10
Gross proceeds from issuance	$ 66,810,000